Clinical Trial Update: Biodistribution and Dosimetry Evaluation of [124I]FIAU [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating the biodistribution and dosimetry of the radiotracer [124I]FIAU in prosthetic joint infections; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prosthetic Joint Infection

Drugs mentioned

• [124I]FIAU (FIAU radiotracer labeled with iodine-124)

Snippet

Sponsor: BioMed Valley Discoveries, Inc | Conditions: Prosthesis Related Infections | Phase 1 | Status: COMPLETED